Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
139M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
30.1M
-
Shares change
-
+9.53M
-
Total reported value, excl. options
-
$221M
-
Value change
-
+$70.4M
-
Put/Call ratio
-
2.08
-
Number of buys
-
54
-
Number of sells
-
-26
-
Price
-
$7.35
Significant Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q3 2016
114 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") as of Q3 2016.
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.1M shares
of 139M outstanding shares and own 21.71% of the company stock.
Largest 10 shareholders include OppenheimerFunds, Inc. (3M shares), QVT Financial LP (2.56M shares), BlackRock Fund Advisors (2.49M shares), VANGUARD GROUP INC (2.48M shares), ORBIMED ADVISORS LLC (2.16M shares), BAKER BROS. ADVISORS LP (1.86M shares), BlackRock Institutional Trust Company, N.A. (1.72M shares), RA CAPITAL MANAGEMENT, LLC (1.53M shares), JPMORGAN CHASE & CO (1.49M shares), and STATE STREET CORP (1.39M shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.